Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 0 | 10,000 | 0 | 0 | 0 |
| Gross Profit | N/A | 10,000 | N/A | N/A | N/A |
| Operating Expenses | 72,505 | 31,325 | 25,586 | 25,897 | 24,008 |
| Operating Income | -72,505 | -21,325 | -25,586 | -25,897 | -24,008 |
| Interest Expense | 336 | 1,080 | 1,337 | 913 | 755 |
| Other Income | 293 | -5,152 | 252 | 11,281 | -7,154 |
| Pre-tax Income | -72,548 | -27,557 | -26,671 | -15,529 | -31,917 |
| Net Income Continuous | -72,548 | -27,557 | -26,671 | -15,529 | -31,917 |
| Net Income | $-72,548 | $-27,557 | $-26,671 | $-15,529 | $-31,917 |
| EPS Basic Total Ops | -1.25 | -0.79 | -1.14 | -0.82 | -2.65 |
| EPS Basic Continuous Ops | -1.26 | -0.79 | -1.14 | -0.82 | -2.65 |
| EPS Diluted Total Ops | -1.26 | -0.79 | -1.14 | -0.83 | -2.65 |
| EPS Diluted Continuous Ops | -1.25 | -0.79 | -1.14 | -0.82 | -2.65 |
| EPS Diluted Before Non-Recurring Items | -1.26 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-74,345 | $-21,489 | $-25,432 | $-25,364 | $-23,537 |